Table 6.
Total |
ADT (−)
n = 258 |
ADT < 2Y
n = 732 |
ADT ≥ 2Y
n = 135 |
|||
Cardiovascular | 3 | (0.4%) | 2 | (1.5%) | ||
Cerebrovascular | 3 | (0.4%) | 2 | (1.5%) | ||
Other malignancies | 7 | (2.7%) | 25 | (3.4%) | 7 | (5.2%) |
Other | 2 | (0.8%) | 5 | (0.7%) | 2 | (1.5%) |
Unknown | 2 | (0.8%) | 6 | (0.8%) | 5 | (3.7%) |
Elder ≥ 75 | n = 46 | n = 164 | n = 34 | |||
Cardiovascular | 2 | (1.2%) | ||||
Cerebrovascular | 1 | (2.9%) | ||||
Other malignancies | 1 | (2.2%) | 11 | (6.7%) | 2 | (5.9%) |
Other | 1 | (2.2%) | 2 | (1.2%) | 1 | (2.9%) |
Unknown | 1 | (0.6%) | 4 | (11.8%) | ||
Young < 75 | n = 212 | n = 568 | n = 101 | |||
Cardiovascular | 1 | (0.2%) | 2 | (2.0%) | ||
Cerebrovascular | 3 | (0.5%) | 1 | (1.0%) | ||
Other malignancies | 6 | (2.8%) | 14 | (2.5%) | 5 | (5.0%) |
Other | 1 | (0.5%) | 3 | (0.5%) | 1 | (1.0%) |
Unknown | 2 | (0.9%) | 5 | (0.9%) | 1 | (1.0%) |
ADT = androgen deprivation therapy; 2Y = 2 years.